Metraipolis › archive › dc_f6da62ecdad8

Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome — Europe PMC PMID:42755381

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42755381
DOI
10.57264/cer-2026-0138
License (as archived)
solo-consultazione
Archived
2026-10-09T22:20:07.441Z
SHA-256 of the archived text
f7bb32ba42c6fe0944ae69101c23c5a6838464ed884e72bdfa3ca67eac58c8b3
Stable URL of this page
https://metraipolis.com/documento/dc_f6da62ecdad8

How to cite

Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome — Europe PMC PMID:42755381 — Europe PMC (en), https://europepmc.org/article/MED/42755381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6da62ecdad8 (Metraipolis archive dc_f6da62ecdad8, sha256 f7bb32ba42c6fe0944ae69101c23c5a6838464ed884e72bdfa3ca67eac58c8b3)
BibTeX
@misc{dcf6da62ecdad8,
  title = {Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome — Europe PMC PMID:42755381},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755381},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6da62ecdad8; sha256 f7bb32ba42c6fe0944ae69101c23c5a6838464ed884e72bdfa3ca67eac58c8b3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755381. Agents can read the archived copy with the MCP tool read_document.